Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Division of Dermatology, University of Toronto, Toronto, Ontario, Canada.
Int J Dermatol. 2017 Sep;56(9):902-908. doi: 10.1111/ijd.13578. Epub 2017 Feb 27.
Currently available treatment options for melasma include prevention of UV radiation, topical lightening agents, chemical peels, and light-based and laser therapies. However, none have shown effective and sustained results, with incomplete clearance and frequent recurrences. There has been increasing interest recently in oral medications and dietary supplements in improving melasma. We sought to evaluate the efficacy and safety/tolerability of oral medications and dietary supplements for the treatment of melasma. Multiple databases were systematically searched for randomized clinical trials (RCTs) evaluating the use of oral medication for treatment of melasma alone or in combination with other treatments. A total of eight RCTs met inclusion criteria. Oral medications and dietary supplements evaluated include tranexamic acid, Polypodium leucotomos extract, beta-carotenoid, melatonin, and procyanidin. These agents appear to have a beneficial effect on melasma improvement. In conclusion, oral medications have a role in melasma treatment and have been shown to be efficacious and tolerable with a minimal number and severity of adverse events. Therefore, dermatologists should keep oral medications and dietary supplements in their armamentarium for the treatment of melasma.
目前,治疗黄褐斑的方法包括预防紫外线辐射、局部美白剂、化学换肤、光疗和激光治疗。然而,这些方法都没有显示出有效的和持续的结果,清除不彻底且经常复发。最近,人们对口服药物和膳食补充剂在改善黄褐斑方面的作用越来越感兴趣。我们试图评估口服药物和膳食补充剂治疗黄褐斑的疗效、安全性和耐受性。系统地检索了多个数据库,以寻找评估口服药物单独或联合其他治疗方法治疗黄褐斑的随机临床试验(RCT)。共有八项 RCT 符合纳入标准。评估的口服药物和膳食补充剂包括氨甲环酸、舞茸提取物、β-胡萝卜素、褪黑素和原花青素。这些药物似乎对改善黄褐斑有一定效果。总之,口服药物在黄褐斑的治疗中有一定作用,已被证明是有效且耐受的,不良反应的数量和严重程度都较低。因此,皮肤科医生应该在治疗黄褐斑时将口服药物和膳食补充剂纳入其治疗方案中。